Martin Karjalainen

Martin Karjalainen is a seasoned medical professional with extensive experience in clinical research and development. Currently serving as a Doktor der Medizin at medac GmbH since June 2020, Martin specializes in Drug Device Combination Products. From January 2010 to January 2024, Martin held the position of Clinical Scientific Program Lead at Allergopharma GmbH & Co. KG, a subsidiary of Merck. Prior to that, Martin worked as a Medical Advisor in Clinical Development at Universitätsklinikum Hamburg Eppendorf and served as a physician in the Neurological Clinic's headache outpatient unit. Martin co-founded and led the Clinical Trial Center North from April 2006 to April 2009, contributing significantly to its establishment. Early career roles included serving as an Early Clinical Research Physician at MDS Pharma Services Germany GmbH and as a physician in Internal Medicine at Albertinen Krankenhaus. Martin's educational background includes degrees from the University of Hamburg, culminating in training as a specialist in Clinical Pharmacology.